Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125256) titled 'Evaluation of the efficacy and safety of dexmedetomidine nasal spray inBronchoscopy Examination' on May 24.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Quzhou People Hospital
Condition:
None
Intervention:
Normal Saline Group:Normal saline spray was evenly administered into both nostrils of the patients 30 minutes before the operation.
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-05-30
Target Sample Size: Normal Saline Group:35;Dexmedetomidine Nasal Spray Group:35;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.c...